Organisation paid for research Program year 2023 Source: CMS Open Payments

Aids Healthcare Foundation-340B

Neither a doctor nor a teaching hospital

Research payments

$1,254,114

220 payments

Through program year 2023, Aids Healthcare Foundation-340B is reported as receiving $1,254,114 in research payments, across 220 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2023	Research	$171,308	44
2022	Research	$190,459	60
2021	Research	$653,194	89
2020	Research	$239,153	27

Breakdown

Who paid Research payments · program years 2020–2023

ViiV Healthcare Company $1,229,044 210 payments
GlaxoSmithKline, LLC. $25,071 10 payments

Studies the money was for Research payments · program years 2020–2023

A Phase III, Randomized, Multicenter, Parallel-Group, Non-Inferiority $404,644 57 payments
A Phase Iiib, Randomized, Multicenter, Active-Controlled, Parallel-Gro $390,365 88 payments
A Qualitative Hybrid III Implementation Study to Identify and Evaluate $351,069 38 payments
A Phase III, Randomized, Multicenter, Open-Label, Non-Inferiority Stud $73,415 19 payments
A Phase Iiib, Multi-Center, Non-Randomized, Parallel-Group, Open-Label $17,271 7 payments
A Phase 2B Multicenter, Randomized, Open-Label Study Comparing the Eff $6,000 1 payment
A Phase 4, Randomized, Open-Label, Two-Arm Study Evaluating Implementa $4,550 2 payments
A Phase III, Randomised, Double-Blind, Multicentre, Parallel-Group, No $3,138 5 payments
A Phase Iib, Randomized, Double-Blind, Parallel-Group Study to Assess $1,862 1 payment
A Descriptive, Prospective, Multi-Country, Multicentre Study to Assess $1,800 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.